UNSPSC 51172471: Isopropamide/prochlorperazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA900. This VA Drug Class (GA900) classifies this compound as belonging to the group GASTRIC MEDICATIONS, OTHER.

UNSPSC 51172471 Isopropamide/prochlorperazine is a Commodity code nominally identifying a specific antispasmodic pharmaceutical, but the recent state and local opportunities posted under this code do not align with procurement of that chemical compound. Instead, the code appears in three distinct pharmaceutical and testing service procurements: offender drug testing specimen collection and laboratory analysis, a market-intelligence RFI on direct-to-manufacturer prescription sourcing, and a cooperative purchasing RFP for generic multi-source pharmaceuticals and OTC products. The mismatch between the code name and actual buying activity suggests the code is being applied inconsistently or mistagged in state procurement systems. State and local issuing bodies using this code include county supervision and corrections departments, state health and human services commissions, and cooperative purchasing alliances administered by state procurement offices on behalf of multi-state member jurisdictions including correctional, healthcare, and human services entities.

Recent activity centers in Texas and Minnesota. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services with a July 23, 2026 response deadline, seeking immunoassay screening with confirmation, result reporting, and alternative testing modalities for approximately 25,031 annual tests at an estimated contract value of $600,000 over two years with three optional one-year renewals. The Texas Health and Human Services Commission posted RFI HHS0017013 on March 27, 2026 (response deadline April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription contracting outside traditional PBM and GPO channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 with proposals due March 26, 2026 to establish multi-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers to participating state and local government facilities across Minnesota and Oregon, with awarded products effective July 1, 2026. The disparity between the code's stated pharmaceutical and the range of testing, sourcing strategy, and bulk pharmaceutical procurement activity suggests caution in relying on this code alone for market intelligence; confirm actual commodity need with issuing bodies before pursuing.